Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C

G. McHutchison, John; C. Gordon, Stuart; R. Schiff, Eugene; L. Shiffman, Mitchell; M. Lee, William; K. Rustgi, Vinod; Goodman, Zachary; Ling, Mei–Hsiu; Cort, Susannah; K. Albrecht, Janice

doi:10.1056/nejm199811193392101

Public

Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C

Published in New England Journal of Medicine • Nov 19, 1998

Authors:

John G. McHutchison

Stuart C. Gordon

Eugene R. Schiff

Abstract

BACKGROUND: Only 15 to 20 percent of patients with chronic hepatitis C have a sustained virologic response to interferon therapy. We compared the efficacy and safety of recombinant interferon alfa-2b alone with those of a combination of interferon alfa-2b and ribavirin for the initial treatment of p...

Subject

Medicine

Ribavirin

Gastroenterology

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!